SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-008127
Filing Date
2020-02-10
Accepted
2020-02-10 19:49:53
Documents
1
Period of Report
2020-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4256
  Complete submission text file 0001209191-20-008127.txt   5813
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 TECHNOLOGY SQUARE, 10TH FLOOR CAMBRIDGE MA 02139
Business Address 400 TECHNOLOGY SQUARE, 10TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Atlas Venture Opportunity Fund I, L.P. (Reporting) CIK: 0001759241 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 20593480